Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2016

Open Access 01-10-2016 | Original Article

Trends in ExPEC serogroups in the UK and their significance

Authors: H. Ciesielczuk, C. Jenkins, M. Chattaway, M. Doumith, R. Hope, N. Woodford, D. W. Wareham

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2016

Login to get access

Abstract

Extra-intestinal pathogenic Escherichia coli are a significant cause of urinary tract infection and bacteraemia within the UK. We sought to identify the serogroups of 658 E. coli isolates collected in the UK between January 2011 and March 2012, to better understand the ExPEC population and understand the relevance of serogroups in this pathotype. Isolates were typed and serogroup identified using established phenotypic and molecular methods. Sixty-two serogroups were identified; 54 among urinary isolates and 35 among bloodstream isolates. However, serogroups O25, O6, and O2 dominated both infection types. These serogroups were linked to the major ExPEC STs as follows: ST131-O25, ST73-O6, ST127-O6, and ST95-O2. The serogroup data from this study have increased our understanding of the ExPEC population in the UK, but also highlighted key ST–serogroup relationships within the major ExPEC clones. These data can be used to guide vaccine design and in the development of laboratory diagnostic tests targeting the ExPEC population.
Literature
1.
go back to reference Lau S, Reddy S, Cheesbrough J, Bolton F, Willshaw G, Cheasty T et al (2008) Major uropathogenic Escherichia coli strain isolated in the North West of England identified by multilocus sequence typing. J Clin Microbiol 46(3):1076–1080CrossRefPubMedPubMedCentral Lau S, Reddy S, Cheesbrough J, Bolton F, Willshaw G, Cheasty T et al (2008) Major uropathogenic Escherichia coli strain isolated in the North West of England identified by multilocus sequence typing. J Clin Microbiol 46(3):1076–1080CrossRefPubMedPubMedCentral
2.
go back to reference Gibreel T, Dodgson A, Cheesbrough J, Fox A, Bolton F, Upton M (2012) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67(2):346–356CrossRefPubMed Gibreel T, Dodgson A, Cheesbrough J, Fox A, Bolton F, Upton M (2012) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67(2):346–356CrossRefPubMed
3.
go back to reference Horner C, Fawley W, Morris K, Parnell P, Denton M, Wilcox M (2014) Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010–12). J Antimicrob Chemother 69(1):91–100CrossRefPubMed Horner C, Fawley W, Morris K, Parnell P, Denton M, Wilcox M (2014) Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010–12). J Antimicrob Chemother 69(1):91–100CrossRefPubMed
4.
go back to reference Emanghoraishi F, Farshad S, Kalani M (2011) Relationship between O serotype and virulent genes in Escherichia coli causing urinary tract infections. Iran J Kidney Dis 5(4):234–237 Emanghoraishi F, Farshad S, Kalani M (2011) Relationship between O serotype and virulent genes in Escherichia coli causing urinary tract infections. Iran J Kidney Dis 5(4):234–237
5.
go back to reference Johnson J, Russo T (2002) Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections. J Infect Dis 186(6):859–864CrossRefPubMed Johnson J, Russo T (2002) Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections. J Infect Dis 186(6):859–864CrossRefPubMed
6.
go back to reference Poolman JT, Wacker M (2016) Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J Infect Dis 213(1):6–13CrossRefPubMed Poolman JT, Wacker M (2016) Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J Infect Dis 213(1):6–13CrossRefPubMed
7.
go back to reference Chakupurakal R, Ahmed M, Sobithadevi D, Chinnappan S, Reynolds T (2010) Urinary tract pathogens and resistance pattern. J Clin Pathol 63(7):652–654CrossRefPubMed Chakupurakal R, Ahmed M, Sobithadevi D, Chinnappan S, Reynolds T (2010) Urinary tract pathogens and resistance pattern. J Clin Pathol 63(7):652–654CrossRefPubMed
8.
go back to reference Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko EV et al (2013) The clonal distribution and diversity of extraintestinal Escherichia coli varies according to patient characteristics. Antimicrob Agents Chemother 57(12):5912–5917CrossRefPubMedPubMedCentral Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko EV et al (2013) The clonal distribution and diversity of extraintestinal Escherichia coli varies according to patient characteristics. Antimicrob Agents Chemother 57(12):5912–5917CrossRefPubMedPubMedCentral
9.
go back to reference Abdallah KS, Cao Y, Wei DJ (2011) Epidemiologic investigation of extra-intestinal pathogenic E. coli (ExPEC) based on PCR phylogenetic group and fimH single nucleotide polymorphisms (SNPs) in China. Int J Mol Epidemiol Genet 2(4):339–353PubMedPubMedCentral Abdallah KS, Cao Y, Wei DJ (2011) Epidemiologic investigation of extra-intestinal pathogenic E. coli (ExPEC) based on PCR phylogenetic group and fimH single nucleotide polymorphisms (SNPs) in China. Int J Mol Epidemiol Genet 2(4):339–353PubMedPubMedCentral
10.
go back to reference Russo T, Johnson J (2000) Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 181(5):1753–1754CrossRefPubMed Russo T, Johnson J (2000) Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 181(5):1753–1754CrossRefPubMed
11.
go back to reference Underwood AP, Dallman T, Thomson NR, Williams M, Harker K, Perry N et al (2013) Public health value of next-generation DNA sequencing of enterohemorrhagic Escherichia coli isolates from an outbreak. J Clin Microbiol 51(1):232–237CrossRefPubMedPubMedCentral Underwood AP, Dallman T, Thomson NR, Williams M, Harker K, Perry N et al (2013) Public health value of next-generation DNA sequencing of enterohemorrhagic Escherichia coli isolates from an outbreak. J Clin Microbiol 51(1):232–237CrossRefPubMedPubMedCentral
12.
go back to reference Monecke S, Mariani-Kurkdjian P, Bingen E, Weill FX, Baliere C, Slickers P et al (2011) Presence of enterohemorrhagic Escherichia coli ST678/O104:H4 in France prior to 2011. Appl Environ Microbiol 77(24):8784–8786CrossRefPubMedPubMedCentral Monecke S, Mariani-Kurkdjian P, Bingen E, Weill FX, Baliere C, Slickers P et al (2011) Presence of enterohemorrhagic Escherichia coli ST678/O104:H4 in France prior to 2011. Appl Environ Microbiol 77(24):8784–8786CrossRefPubMedPubMedCentral
13.
go back to reference Nicolas-Chanoine M, Blanco J, Leflon-Guibout V, Demarty R, Alonso M, Canica M et al (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61(2):273–281CrossRefPubMed Nicolas-Chanoine M, Blanco J, Leflon-Guibout V, Demarty R, Alonso M, Canica M et al (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61(2):273–281CrossRefPubMed
14.
go back to reference Johnson JR, Johnston B, Clabots CR, Kuskowski MA, Roberts E, DebRoy C (2008) Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J Clin Microbiol 46(2):417–422CrossRefPubMed Johnson JR, Johnston B, Clabots CR, Kuskowski MA, Roberts E, DebRoy C (2008) Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J Clin Microbiol 46(2):417–422CrossRefPubMed
15.
go back to reference Day M, Doumith M, Abernethy J, Hope R, Reynolds R, Wain J et al (2016) The population structure of Escherichia coli causing bacteraemia in the UK and Ireland between 2001 and 2010. J Antimicrob Chemother [Accepted for publication] Day M, Doumith M, Abernethy J, Hope R, Reynolds R, Wain J et al (2016) The population structure of Escherichia coli causing bacteraemia in the UK and Ireland between 2001 and 2010. J Antimicrob Chemother [Accepted for publication]
16.
go back to reference Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham D (2013) Development and evaluation of a multiplex pcr for eight plasmid-mediated quinolone resistance determinants. J Med Microbiol 62(Pt 12):1823–1827CrossRefPubMed Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham D (2013) Development and evaluation of a multiplex pcr for eight plasmid-mediated quinolone resistance determinants. J Med Microbiol 62(Pt 12):1823–1827CrossRefPubMed
17.
go back to reference Reynolds R, Hope R, Williams L (2008) Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes. J Antimicrob Chemother 62(suppl 2):ii15–ii28PubMed Reynolds R, Hope R, Williams L (2008) Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes. J Antimicrob Chemother 62(suppl 2):ii15–ii28PubMed
18.
go back to reference Gross R, Rowe B (1985) Serotyping of Escherichia coli. In: Sussman M (ed) The virulence of Escherichia coli. Cambridge University Press, Cambridge, pp 345–360 Gross R, Rowe B (1985) Serotyping of Escherichia coli. In: Sussman M (ed) The virulence of Escherichia coli. Cambridge University Press, Cambridge, pp 345–360
19.
go back to reference Doumith M, Day M, Hope R, Wain J, Woodford N (2012) Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol 50(9):3108–3110CrossRefPubMedPubMedCentral Doumith M, Day M, Hope R, Wain J, Woodford N (2012) Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol 50(9):3108–3110CrossRefPubMedPubMedCentral
20.
go back to reference Doumith M, Day M, Ciesielczuk H, Hope R, Underwood A, Reynolds R et al (2014) Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol 53(1):160–166CrossRefPubMedPubMedCentral Doumith M, Day M, Ciesielczuk H, Hope R, Underwood A, Reynolds R et al (2014) Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol 53(1):160–166CrossRefPubMedPubMedCentral
21.
go back to reference Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB (2006) Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect 8(7):1702–1713CrossRefPubMed Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB (2006) Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect 8(7):1702–1713CrossRefPubMed
22.
go back to reference Novais A, Vuotto C, Pires J, Montenegro C, Donelli G, Coque TM et al (2013) Diversity and biofilm-production ability among isolates of Escherichia coli phylogroup D belonging to ST69, ST393 and ST405 clonal groups. BMC Microbiol 13:144CrossRefPubMedPubMedCentral Novais A, Vuotto C, Pires J, Montenegro C, Donelli G, Coque TM et al (2013) Diversity and biofilm-production ability among isolates of Escherichia coli phylogroup D belonging to ST69, ST393 and ST405 clonal groups. BMC Microbiol 13:144CrossRefPubMedPubMedCentral
23.
go back to reference Cagnacci S, Gualco L, Debbia E, Schito G, Marchese A (2008) European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 46(8):2605–2612CrossRefPubMedPubMedCentral Cagnacci S, Gualco L, Debbia E, Schito G, Marchese A (2008) European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 46(8):2605–2612CrossRefPubMedPubMedCentral
24.
go back to reference Alghoribi MF, Gibreel TM, Dodgson AR, Beatson SA, Upton M (2014) Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli. PLoS One 9(7):e101547CrossRefPubMedPubMedCentral Alghoribi MF, Gibreel TM, Dodgson AR, Beatson SA, Upton M (2014) Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli. PLoS One 9(7):e101547CrossRefPubMedPubMedCentral
25.
go back to reference Manges A, Tabor H, Tellis P, Vincent C, Tellier P (2008) Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 14(10):1575–1583CrossRefPubMedPubMedCentral Manges A, Tabor H, Tellis P, Vincent C, Tellier P (2008) Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 14(10):1575–1583CrossRefPubMedPubMedCentral
26.
go back to reference Melzer M, Petersen I, Cheasty T (2008) The difference in serotypes between extended-beta-lactamase (ESBL) and non-ESBL-producing E. coli blood culture isolates at a UK district general hospital. J Hosp Infect 68(4):367–369CrossRefPubMed Melzer M, Petersen I, Cheasty T (2008) The difference in serotypes between extended-beta-lactamase (ESBL) and non-ESBL-producing E. coli blood culture isolates at a UK district general hospital. J Hosp Infect 68(4):367–369CrossRefPubMed
27.
go back to reference Ananias M, Yano T (2008) Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 41(10):877–883CrossRefPubMed Ananias M, Yano T (2008) Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 41(10):877–883CrossRefPubMed
Metadata
Title
Trends in ExPEC serogroups in the UK and their significance
Authors
H. Ciesielczuk
C. Jenkins
M. Chattaway
M. Doumith
R. Hope
N. Woodford
D. W. Wareham
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2707-8

Other articles of this Issue 10/2016

European Journal of Clinical Microbiology & Infectious Diseases 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.